Thomas A. Nahass, MD, MS

Father, Husband, Critical Care, Clinical Informatics, running

[IDSA @IDSAInfo]

IDSA’s recent elections, along with the appointment of current IDSA Treasurer Jeanne Marrazzo, MD, FIDSA (@DrJeanneM) as the next @NIAIDNews director, will bring a new slate of Board members to the Society effective Oct. 16.

Learn more: https://t.co/HHrlWGK8aT

[Payal Parikh, MD, FACP @Payalia320]

The #DOM Nahass siblings catching up on medicine, training, attending experiences and more at a Friday afternoon coffee break! @TomNahass @RWJMS #wellness @RutgersRWJcards @CareRutgers @RWJBarnabas #nationallyrecognizedin12areas!

[RutgersPulmonaryCriticalCare @CareRutgers]

Summer airway sessions under way! Thanks to St Peter's hospital for collaborating with us! @RWJBarnabas @ATSMedEd

[Critical Care Reviews @CritCareReviews]

The Critical Care Reviews Book 2022 is now available
https://t.co/R5ABzJVlI8
#CCR22

➡️Best trials of 2021 summarised, critiqued & contextualised
➡️Available as free pdf or physical book
➡️For those in high income countries, we suggest making a small donation to support our work

[Yo-Yo Ma @YoYo_Ma]

Some musical gratitude for all the healthcare workers who do the impossible every day.

Simple Gifts, #songsofcomfort

[Eric Topol @EricTopol]

Impressive new data for real-world effectiveness (VE) of Moderna vaccine in a prospective study of >350,000 vaccinees & matched unvaccinated individuals, w/ virus sequencing
https://t.co/HgnRfeJ3tz
VE hospitalization 96%, symptomatic infection 88%
@BruxvoortKatia @KPSCalResearch

[ron nahass @ronnahass]

Choosing the right COVID-19 mask — 5 things to know https://t.co/67iYdz79OP @nj1015

[Eric Topol @EricTopol]

Encouraging new commentary about the very small risk of surface/fomite transmission of #SARSCoV2
https://t.co/bZxqVLwFRz @TheLancetInfDis by Emanuel Goldman @Rutgers_NJMS

[Thomas A. Nahass, MD, MS @TomNahass]

Elton John just has a piano in his driveway? #OneWorldTogetherAtHome

[Thomas A. Nahass, MD, MS @TomNahass]

Unintended consequences of so much fear surrounding COVID

The Untold Toll — The Pandemic’s Effects on Patients without Covid-19 | NEJM https://t.co/ykSQiLyCkK

[Thomas A. Nahass, MD, MS @TomNahass]

Great strides for NLP and use for research with clinical free text notes

[Atul Butte (In Memoriam) @atulbutte]

THRILLED to announce Philter, our new tool to deidentify clinical text. Now more than ever, safe & responsible sharing of #EHR data is needed to fight pandemics & disease, but text is hardest to share. @BeauNorgeot built a new tool w/ a great team! https://t.co/FVGF49ja3a

[Josh Farkas MD 💊 @PulmCrit]

first meaningful RCT on hydroxychloroquine
- no effect on viral clearance (despite huge doses)
- no effect on symptomatic improvement
- increased side effects
- for now, use of hydroxychloroquine should probably be limited to RCTs
(blog https://t.co/2nx0LL1mMO)

[Thomas A. Nahass, MD, MS @TomNahass]

Seems about right with what we are seeing

[Andy Biotech @AndyBiotech]

#COVID19 Here comes another dataset of #Hydroxychloroquine from an open-label randomized controlled trial in China
https://t.co/qW93wMDILK

No difference in 28-day #coronavirus negative conversion rate for HCQ + SOC vs SOC

No difference in 28-day symptoms alleviation rate either

[Eric Topol @EricTopol]

A very good review of what we know of the anti-#COVID19 drug treatments to date
https://t.co/QwMsMyIEQy @JAMA_current by @UTSWNews James Sanders and colleagues

[Thomas A. Nahass, MD, MS @TomNahass]

This. The inability to comfort your patients or their families the way they deserve is incredibly challenging. Proud @RWJMS donated iPads to take on this challenge

Teach your family to use video chat services before they need it. #CovidCompassion #NEJM

https://t.co/a8Q6rK4pGJ

[NEJM @NEJM]

A cohort of patients with severe Covid-19 received treatment with remdesivir under a compassionate-use protocol. Improvement in oxygen-support status was observed in 68% of patients, and overall mortality was 13% over a median follow-up of 26 days. #COVID19

[Thomas A. Nahass, MD, MS @TomNahass]

where is the kitchen sink?

[Josh Farkas MD 💊 @PulmCrit]

fresh study: D-dimer >1,500 strongly correlates with DVT among COVID patients (85% sensi, 89% spec). many limitations, but this supports the concept of empiric anticoagulation if ⬆️⬆️ DDimer & no contraindication.
(fresh blog: https://t.co/sP7Mh82hNF)
#COVID19FOAM

[Thomas A. Nahass, MD, MS @TomNahass]

Give the APL abs maybe some efficacy of the plaquenil similar to effect of the APL during lupus flare? Problem with clots that have already formed, would need to start early. Not seeing great efficacy with plaquenil because they are already hypoxemic and Abs had time to form clot

[NEJM @NEJM]

Correspondence: Coagulopathy in Critical Illness with Covid-19. #COVID19

[Thomas A. Nahass, MD, MS @TomNahass]

@mj_sandel If a 30 something crashes maybe I would consider a hail mary tpa..no evidence and don't know if it's been tried

[Dr Ed Fitzgerald @DrEdFitzgerald]

Guide for telephone and video consults for #COVID19 — strongest stimulus for #DigitalHealth and #telehealth in decades:

▪️Most can be managed remotely
▪️Safety-netting is crucial
▪️Data protection regs relaxing

▶️https://t.co/sIJMxTWVhu @bmj_latest by @trishgreenhalgh